A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 6 47-6, 2003, Pages

  Chen, Jian Wen ^a,d   Ledet, Thomas ^a   Ørskov, Hans ^a   Jessen, Niels ^a   Lund, Sten ^a   Whittaker, Jonathan ^b   De Meyts, Pierre ^b   Larsen, Maj Britt ^a,c   Christiansen, Jens Sandahl ^a   Frystyk, Jan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

^c NOVO NORDISK A S   (Denmark)

^d Aarhus Kommunehospital   (Denmark)

Author keywords

Insulin like growth factor I receptor; Kinase receptor activation assay

Indexed keywords

GENE PRODUCT; GROWTH HORMONE; INSULIN DERIVATIVE; INSULIN LIKE GROWTH FACTOR I KINASE RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; ANALYTIC METHOD; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS REACTION; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; EMBRYO; ENZYME ACTIVATION; GENETIC TRANSFECTION; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN CELL; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR UPREGULATION; SENSITIVITY AND SPECIFICITY;

EID: 0037502831     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00410.2002     Document Type: Article

References (22)

1. Bang P, Ahlsen M, Berg U, and Carlsson-Skwirut C. Free insulin-like growth factor I: are we hunting a ghost? Horm Res 55, Suppl 2: 84-93, 2001.
2. Baxter RC. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278: E967-E976, 2000.
3. Bayes-Genis A, Conover CA, and Schwartz RS. The insulinlike growth factor axis: a review of atherosclerosis and restenosis. Circ Res 86: 125-130, 2000.
4. Daughaday WH and Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10: 68-91, 1989.
5. De Meyts P, Christoffersen CT, Urso B, Wallach B, Grønskov K, Yakushiji F, and Shymko RM. Role of the time factor in signaling specificity: application to mitogenic and metabolic signalling by the insulin and insulin-like growth factor-I receptor tyrosine kinases. Metabolism 44: 2-11, 1995.
6. Ekins R. Measurement of free hormones in blood. Endocr Rev 11: 5-46, 1990.
7. Feldman H and Rodbard D. Mathematical theory of radioimmunoassay. In: Principles of Competitive Protein-Binding Assays, edited by Odell WD and Daughaday WH. Philadelphia, PA: Lippincott, 1971, p. 158-201.
8. Frystyk J, Dinesen B, and Ørskov H. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul 5: 169-176, 1995.
9. Frystyk J, Ivarsen P, Skjærbæk C, Flyvbjerg A, Pedersen EB, and Ørskov H. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int 56: 2076-2084, 1999.
10. Frystyk J, Ivarsen P, Støving RK, Dall R, Bek T, Hagen C, and Ørskov H. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay. Growth Horm IGF Res 11: 117-127, 2001.
11. Frystyk J, Skjærbæk C, Dinesen B, and Ørskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 348: 185-191, 1994.
12. Jones JI and Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34, 1995.
13. Kenner KA and Heidenreich KA. Insulin and insulin-like growth factors stimulate in vivo receptor autophosphorylation and tyrosine phosphorylation of a 70K substrate in cultured fetal chick neurons. Endocrinology 129: 301-311, 1991.
14. Khandwala HM, McCutcheon IE, Flyvbjerg A, and Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21: 215-244, 2000.
15. Kurtzhals P, Schaffer L, Sørensen A, Kristensen C, Jonassen I, Schmid C, and Trub T. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49: 999-1005, 2000.
16. LeRoith D, Bondy C, Yakar S, Liu JL, and Butler A. The somatomedin hypothesis: 2001. Endocr Rev 22: 53-74, 2001.
17. Mynarcik DC, Williams PF, Schaffer L, Yu GQ, and Whittaker J. Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors. Insights into mechanisms of ligand binding. J Biol Chem 272: 18650-18655, 1997.
18. Nielsen FC, Wang E, and Gammeltoft S. Receptor binding, endocytosis, and mitogenesis of insulin-like growth factors I and II in fetal rat brain neurons. J Neurochem 56: 12-21, 1991.
19. Poretsky L, Bhargava G, and Levitan E. Type I insulin-like growth factor receptors in human ovarian stroma. Horm Res 33: 22-26, 1990.
20. Sadick MD. Kinase receptor activation (KIRA): a rapid and accurate alternative to endpoint bioassays. Dev Biol Stand 97: 121-133, 1999.
21. Stephen RL, Shaw LE, Larsen C, Corcoran D, and Darbre PD. Insulin-like growth factor receptor levels are regulated by cell density and by long term estrogen deprivation in MCF7 human breast cancer cells. J Biol Chem 276: 40080-40086, 2001.
22. Weeke J and Ørskov H. Ultrasensitive radioimmunoassay for direct determination of free triiodothyronine concentration in serum. Scand J Clin Lab Invest 35: 237-244, 1975.